PhaseBio Pharmaceuticals Inc SC 13G and SC 13G/A reports

Location
1 Great Valley Parkway, Suite 30, Malvern, PA
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
8/16/2024, 01:30 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report Feb 14, 2023
SC 13G/A Report Feb 14, 2023
SC 13G/A Report SEC SCHEDULE 13G Feb 6, 2023
SC 13G/A Report Jul 19, 2022
SC 13G/A Report Feb 15, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report PHASEBIO PHARMACEUTICALS INC Feb 14, 2022
SC 13G/A Report Feb 14, 2022
SC 13G Report SEC SCHEDULE 13G Feb 4, 2022
SC 13G/A Report SCHEDULE 13G-A FOR PHASEBIO PHARMACEUTICALS, INC. Feb 1, 2022
SC 13G/A Report SEC SCHEDULE 13G Nov 10, 2021
SC 13G/A Report SEC SCHEDULE 13G Aug 10, 2021
SC 13G Report SC 13G May 19, 2021
SC 13G Report SC 13G Mar 24, 2021
SC 13G Report Mar 22, 2021
SC 13G/A Report Feb 16, 2021
SC 13G/A Report SEC SCHEDULE 13G Jan 11, 2021
SC 13G Report Nov 16, 2020
SC 13G/A Report Feb 14, 2020
SC 13G/A Report SEC SCHEDULE 13G Jan 27, 2020
SC 13G/A Report SCHEDULE 13G FOR PHASEBIO PHARMACEUTICALS, INC. BY JOHNSON & JOHNSON, DATED 12.3 Jan 17, 2020
SC 13G Report SCHEDULE 13G HOLDINGS REPORT Apr 22, 2019
SC 13G/A Report SEC SCHEDULE 13G Feb 12, 2019
SC 13G Report SCHEDULE 13G FOR PHASEBIO PHARMACEUTICALS, INC. BY JOHNSON & JOHNSON Jan 22, 2019
SC 13G Report SEC SCHEDULE 13G Nov 13, 2018